Explosive Growth in Obesity Indications: Originally for diabetes, GLP-1 drugs are now predominantly being prescribed off-label and approved for weight loss
Estudios clnicos en lceras venosas (Mulder et al.): reduccin del 64% en rea de lcera vs control a 12 semanas
Read more Oral GLP-1 Pills 2026: Wegovy, Foundayo, and Orforglipron Compared Three oral GLP-1s now have FDA approval: Wegovy pill ($675/mo, Dec 2025), Foundayo orforglipron ($149/mo, April 2026), and Rybelsus (off-label)
IGF-1R protein is overexpressed in more than 40% of breast cancer (BC
Lack of Consumer Awareness: Despite its advantages, copper peptide GHK-Cu is largely obscure among general consumers when compared to popular compounds like as hyaluronic acid or retinol
SHEP Cooperative Research Group